Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 9/20 | 0.47 |
| ▸ | PARP1 | P09874 | 2/20 | 0.47 |
| ▸ | CCR1 | P32246 | 1/20 | 0.40 |
| ▸ | CCR5 | P51681 | 1/20 | 0.40 |
| ▸ | CCR8 | P51685 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 3/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 2/20 | 0.34 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.34 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16661476 | 0.79 | CCR1 (0.44) | ELANEPARP1CCR1CCR5CCR8 | |
| SCHEMBL30667298 | 0.79 | ELANE (0.44) | ELANEPARP1CYP1A2ACHEADORA3 | |
| SCHEMBL13974182 | 0.77 | ELANE (0.44) | ELANEPARP1 | |
| SCHEMBL10147922 | 0.74 | ACHE (0.46) | ELANEPARP1CYP1A2ACHEBCHE | |
| SCHEMBL8404515 | 0.73 | ELANE (0.50) | ELANEPARP1CCR1CCR5CCR8 | |
| SCHEMBL460290 | 0.72 | GPR3 (0.57) | ELANEPARP1CYP1A2 | |
| SCHEMBL29661797 | 0.71 | CCR1 (0.52) | CCR1CCR5CCR8CYP1A2 | |
| SCHEMBL3156746 | 0.71 | CCR1 (0.52) | CCR1CCR5CCR8CYP1A2 | |
| Hydrochloric Acid SCHEMBL10516378 | 0.71 | KDM4E (0.55) | ELANEPARP1CYP1A2 | |
| SCHEMBL28122922 | 0.71 | SMN1; SMN2 (0.53) | CCR1CCR5CCR8CYP1A2PDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12018037-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
| US-20180053868-A1 | PHOTOELECTRIC CONVERSION DEVICE HAVING REFLECTION PLATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-02-22 | — | — | US | disclosed |
| US-20180053868-A1 | PHOTOELECTRIC CONVERSION DEVICE HAVING REFLECTION PLATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-02-22 | — | — | US | disclosed |
| US-20170162808-A1 | PHOTOELECTRIC CONVERSION DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-06-08 | — | — | US | disclosed |
| US-20170162808-A1 | PHOTOELECTRIC CONVERSION DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-06-08 | — | — | US | disclosed |
| US-20160372675-A1 | MACROMOLECULAR COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-12-22 | — | — | US | disclosed |
| US-9512149-B2 | Reactive compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-12-06 | — | — | US | disclosed |
| US-9512149-B2 | Reactive compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-12-06 | — | — | US | disclosed |
| US-9472763-B2 | Macromolecular compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-10-18 | — | — | US | disclosed |
| US-9396831-B2 | Polymer compound and electronic device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-07-19 | — | — | US | disclosed |
| US-20080118773-A1 | Complex Composition, Polymer Complex Compound And Polymer Light-Emitting Device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-05-22 | — | — | US | disclosed |
| US-20080003422-A1 | Polymer Compound, Polymer Thin Film and Polymer Thin Film Device Using the Same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-01-03 | — | — | US | disclosed |
| US-20070224538-A1 | Positive Resist Compositions and Process for the Formation of Resist Patterns With the Same | TOKYO OHKA KOGYO CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070224538-A1 | Positive Resist Compositions and Process for the Formation of Resist Patterns With the Same | TOKYO OHKA KOGYO CO., LTD. (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070142504-A1 | Novel multi-branched polymer | NIPPON SODA CO., LTD. (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20070142504-A1 | Novel multi-branched polymer | NIPPON SODA CO., LTD. (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20070103059-A1 | Composition and polymer light-emitting device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070051922-A1 | Polymer light-emitting material and polymer light-emitting device | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-03-08 | — | — | US | disclosed |
| US-20070040164-A1 | Polymer complex compound and polymer light emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-02-22 | — | — | US | disclosed |
| EP-1752479-A1 | ACRYLIC STAR POLYMER | NIPPON SODA CO., LTD. (JP) | 2007-02-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12018037-B2 | Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound | ORC3, LEF1, OCIAD1 | ELANE 2705/4885PARP1 2442/4885CCR1 2833/4885 |
| US-20160372675-A1 | MACROMOLECULAR COMPOUND | EXOSC4, TRPC6, MRPS22 | ELANE 4454/4885PARP1 540/4885CCR1 288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.